应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02315 百奥赛图-B
未开盘 07-23 16:08:27
7.390
-0.240
-3.15%
最高
7.640
最低
7.260
成交量
7.95万
今开
7.630
昨收
7.630
日振幅
4.98%
总市值
29.52亿
流通市值
8.19亿
总股本
3.99亿
成交额
58.87万
换手率
0.07%
流通股本
1.11亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
百奥赛图-B(02315)下跌10.6%,报7.42元/股
金融界 · 07-19
百奥赛图-B(02315)下跌10.6%,报7.42元/股
百奥赛图-B(02315)股价显著下跌10.602%,现价港币$7.42
阿斯达克财经 · 07-19
百奥赛图-B(02315)股价显著下跌10.602%,现价港币$7.42
百奥赛图-B盘中异动 快速下挫5.15%报8.111港元
自选股智能写手 · 07-18
百奥赛图-B盘中异动 快速下挫5.15%报8.111港元
百奥赛图-B(02315)上涨11.02%,报8.36元/股
金融界 · 07-17
百奥赛图-B(02315)上涨11.02%,报8.36元/股
百奥赛图-B早盘涨超11% 与SOTIO达成多靶点抗体合作协议
新浪港股 · 07-17
百奥赛图-B早盘涨超11% 与SOTIO达成多靶点抗体合作协议
港股异动 | 百奥赛图-B(02315)涨超11% 与SOTIO达成多靶点抗体合作协议
智通财经 · 07-17
港股异动 | 百奥赛图-B(02315)涨超11% 与SOTIO达成多靶点抗体合作协议
百奥赛图-B(02315)股价上升8.765%,现价港币$8.19
阿斯达克财经 · 07-17
百奥赛图-B(02315)股价上升8.765%,现价港币$8.19
百奥赛图-B盘中异动 快速拉升5.58%
自选股智能写手 · 07-17
百奥赛图-B盘中异动 快速拉升5.58%
百奥赛图(02315.HK)与SOTIO达成研究合作选择权及许可协议
阿斯达克财经 · 07-17
百奥赛图(02315.HK)与SOTIO达成研究合作选择权及许可协议
百奥赛图-B(02315)与SOTIO达成多靶点抗体合作协议 有权获得首付款和潜在的里程碑付款高达3.255亿美元
智通财经网 · 07-16
百奥赛图-B(02315)与SOTIO达成多靶点抗体合作协议 有权获得首付款和潜在的里程碑付款高达3.255亿美元
SOTIO与百奥赛图达成多靶点抗体合作协议,扩大ADC产品管线
美国商业资讯 · 07-16
SOTIO与百奥赛图达成多靶点抗体合作协议,扩大ADC产品管线
百奥赛图IPO:存货占比增大 连亏3年平均年亏近5亿元
GPLP犀牛财经 · 07-09
百奥赛图IPO:存货占比增大 连亏3年平均年亏近5亿元
百奥赛图-B盘中异动 下午盘急速拉升5.10%
自选股智能写手 · 07-03
百奥赛图-B盘中异动 下午盘急速拉升5.10%
百奥赛图-B盘中异动 快速跳水5.11%
自选股智能写手 · 07-02
百奥赛图-B盘中异动 快速跳水5.11%
百奥赛图-B(02315)股价下跌5.098%,现价港币$7.26
阿斯达克财经 · 07-02
百奥赛图-B(02315)股价下跌5.098%,现价港币$7.26
百奥赛图-B(02315)上涨5.68%,报7.82元/股
金融界 · 06-28
百奥赛图-B(02315)上涨5.68%,报7.82元/股
百奥赛图-B盘中异动 下午盘快速上涨5.39%
自选股智能写手 · 06-28
百奥赛图-B盘中异动 下午盘快速上涨5.39%
“中国鼠王”
重庆商报 · 06-28
“中国鼠王”
百奥赛图(02315.HK)共轻链小鼠RenLite技术平台获得美国专利授权
阿斯达克财经 · 06-21
百奥赛图(02315.HK)共轻链小鼠RenLite技术平台获得美国专利授权
百奥赛图-B(02315)全人共轻链小鼠RenLite®技术平台获美国专利及商标局专利授权
金吾财讯 · 06-21
百奥赛图-B(02315)全人共轻链小鼠RenLite®技术平台获美国专利及商标局专利授权
暂无数据
公司概况
公司名称:
百奥赛图-B
所属市场:
SEHK
上市日期:
--
主营业务:
北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。该公司运营两个业务部门。药物开发业务部门主要从事肿瘤学和自身免疫性疾病治疗的研发,及抗体开发业务。临床前研究服务部门主要从事基因编辑、临床前药理药效评估及模式动物销售。
发行价格:
--
{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奥赛图-B","latestPrice":7.39,"timestamp":1721722107030,"preClose":7.63,"halted":0,"volume":79500,"delay":0,"floatShares":110781920,"shares":399398420,"eps":-1.0297271,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.24,"latestTime":"07-23 16:08:27","open":7.63,"high":7.64,"low":7.26,"amount":588745,"amplitude":0.049803,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.02972711189461,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721784600000},"adr":0,"listingDate":1661961600000,"adjPreClose":7.63,"openAndCloseTimeList":[[1721698200000,1721707200000],[1721710800000,1721721600000]],"volumeRatio":0.5540069684480812,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02315/tweets","defaultTab":"tweets","newsList":[{"id":"2452443287","title":"百奥赛图-B(02315)下跌10.6%,报7.42元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452443287","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452443287?lang=zh_cn&edition=full","pubTime":"2024-07-19 15:33","pubTimestamp":1721374405,"startTime":"0","endTime":"0","summary":"7月19日,百奥赛图-B(02315)盘中下跌10.6%,截至15:33,报7.42元/股,成交100.07万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司,拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台,已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发,已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2023年年报,百奥赛图-B营业总收入7.17亿元、净利润-3.83亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/19153341670594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2452749296","title":"百奥赛图-B(02315)股价显著下跌10.602%,现价港币$7.42","url":"https://stock-news.laohu8.com/highlight/detail?id=2452749296","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452749296?lang=zh_cn&edition=full","pubTime":"2024-07-19 11:03","pubTimestamp":1721358180,"startTime":"0","endTime":"0","summary":"[下跌股]百奥赛图-B(02315) 股价在上午11:03比前收市价显著下跌10.602%,现股价为港币$7.42。至目前为止,今日最高价为$8.1,而最低价为$7.42。总成交量为3.2万股,总成交金额为港币$24.588万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2407192823/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2452144986","title":"百奥赛图-B盘中异动 快速下挫5.15%报8.111港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452144986","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452144986?lang=zh_cn&edition=full","pubTime":"2024-07-18 10:26","pubTimestamp":1721269605,"startTime":"0","endTime":"0","summary":"2024年07月18日早盘10时26分,百奥赛图-B股票出现波动,股价急速下跌5.15%。百奥赛图-B股票所在的生物技术行业中,整体涨幅为0.29%。消息层面,截至10时26分,百奥赛图-B股票正面舆情新闻比例77.78%。SOTIO和百奥赛图将在双特异性项目研究阶段紧密合作,SOTIO将负责ADC产品的非临床和临床开发、生产及商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718102646aefa3cf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718102646aefa3cf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2452046099","title":"百奥赛图-B(02315)上涨11.02%,报8.36元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452046099","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452046099?lang=zh_cn&edition=full","pubTime":"2024-07-17 13:14","pubTimestamp":1721193298,"startTime":"0","endTime":"0","summary":"7月17日,百奥赛图-B(02315)盘中上涨11.02%,截至13:14,报8.36元/股,成交101.45万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司,拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台,已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发,已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2023年年报,百奥赛图-B营业总收入7.17亿元、净利润-3.83亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/17131441615511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2452090346","title":"百奥赛图-B早盘涨超11% 与SOTIO达成多靶点抗体合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2452090346","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452090346?lang=zh_cn&edition=full","pubTime":"2024-07-17 11:38","pubTimestamp":1721187534,"startTime":"0","endTime":"0","summary":"百奥赛图-B(02315)早盘上涨11.42%,现报8.39港元,成交额93.03万港元。\n 百奥赛图公布,公司与SOTIO Biotech(SOTIO)达成一项研究合作和独家选择权及许可协议,据此,SOTIO获授予选择权来获得利用百奥赛图专有的RenLite®平台产生的多种全人源双特异性抗体的许可,而SOTIO将利用这些抗体进行靶向实体瘤的下一代抗体偶联药物(ADCs)开发。协议还包括允许SOTIO使用百奥赛图专有 ADC平台的一项选择权。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-17/doc-incemcmf3165592.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-17/doc-incemcmf3165592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2452903313","title":"港股异动 | 百奥赛图-B(02315)涨超11% 与SOTIO达成多靶点抗体合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2452903313","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452903313?lang=zh_cn&edition=full","pubTime":"2024-07-17 11:29","pubTimestamp":1721186962,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,百奥赛图-B涨超11%,截至发稿,涨11.55%,报8.4港元,成交额88.86万港元。协议还包括允许SOTIO使用百奥赛图专有 ADC平台的一项选择权。SOTIO和百奥赛图将在双特异性项目研究阶段紧密合作,SOTIO将负责ADC产品的非临床和临床开发、生产及商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151909.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07226","HSTECH","HSCEI","BK1161","02315","YANG"],"gpt_icon":0},{"id":"2452293908","title":"百奥赛图-B(02315)股价上升8.765%,现价港币$8.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2452293908","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452293908?lang=zh_cn&edition=full","pubTime":"2024-07-17 11:09","pubTimestamp":1721185740,"startTime":"0","endTime":"0","summary":"[上升股]百奥赛图-B(02315) 股价在上午11:09比前收市价上升8.765%,现股价为港币$8.19。至目前为止,今日最高价为$8.19,而最低价为$7.7。总成交量为8.5万股,总成交金额为港币$67.332万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240717816/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2452927974","title":"百奥赛图-B盘中异动 快速拉升5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452927974","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452927974?lang=zh_cn&edition=full","pubTime":"2024-07-17 10:12","pubTimestamp":1721182367,"startTime":"0","endTime":"0","summary":"2024年07月17日早盘10时12分,百奥赛图-B股票出现波动,股价快速上涨5.58%。百奥赛图-B股票所在的生物技术行业中,整体涨幅为0.59%。消息层面,截至10时12分,百奥赛图-B股票正面舆情新闻比例100%。SOTIO和百奥赛图将在双特异性项目研究阶段紧密合作,SOTIO将负责ADC产品的非临床和临床开发、生产及商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717101248941f7a97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717101248941f7a97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2452194807","title":"百奥赛图(02315.HK)与SOTIO达成研究合作选择权及许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2452194807","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452194807?lang=zh_cn&edition=full","pubTime":"2024-07-17 01:20","pubTimestamp":1721150400,"startTime":"0","endTime":"0","summary":"百奥赛图-B(02315.HK) 公布,与SOTIO达成一项研究合作和独家选择权及许可协议,据此,SOTIO获授选择权获得利用公司专有的RenLite平台产生的多种全人源双特异性抗体的许可,而SOTIO将利用这些抗体进行靶向实体瘤的下一代抗体偶联药物开发。按协议条款,公司有权获得首付款和潜在的里程碑付款高达3.255亿美元,以及基于净销售额的低个位数百分比特许权使用费。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220819091442631_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220819091442631_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1364097/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2451993360","title":"百奥赛图-B(02315)与SOTIO达成多靶点抗体合作协议 有权获得首付款和潜在的里程碑付款高达3.255亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451993360","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451993360?lang=zh_cn&edition=full","pubTime":"2024-07-16 19:32","pubTimestamp":1721129534,"startTime":"0","endTime":"0","summary":"百奥赛图-B(02315)公布,公司与SOTIO \nBiotech(SOTIO)已...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_4.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_4.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2451996966","title":"SOTIO与百奥赛图达成多靶点抗体合作协议,扩大ADC产品管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2451996966","media":"美国商业资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451996966?lang=zh_cn&edition=full","pubTime":"2024-07-16 12:00","pubTimestamp":1721102400,"startTime":"0","endTime":"0","summary":"协议还包括允许SOTIO使用百奥赛图专有ADC平台的一项选择权。SOTIO和百奥赛图将在双特异性项目研究阶段紧密合作,SOTIO将负责ADC产品的非临床和临床开发、生产及商业化。SOTIO是PPF集团的成员。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162012139f55fee3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162012139f55fee3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2450068635","title":"百奥赛图IPO:存货占比增大 连亏3年平均年亏近5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450068635","media":"GPLP犀牛财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450068635?lang=zh_cn&edition=full","pubTime":"2024-07-09 11:59","pubTimestamp":1720497553,"startTime":"0","endTime":"0","summary":"近日,上交所官网显示,百奥赛图(北京)医药科技股份有限公司回复了科创板IPO审核问询函,保荐机构为中金公司。此次IPO,百奥赛图拟公开发行股票数量不超过9984.9605万股,拟募资18.93亿元,将分别用于药物早期研发服务平台建设项目、抗体药物研发及评价项目、临床前及临床研发项目、补充流动资金。2020年至2022年,百奥赛图的存货账面价值分别为5485.30万元、9643.47万元、1.08亿元,占各期末流动资产的比例分别为4.78%、11.03%、11.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407091159199f22c49f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407091159199f22c49f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2448612377","title":"百奥赛图-B盘中异动 下午盘急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448612377","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448612377?lang=zh_cn&edition=full","pubTime":"2024-07-03 13:25","pubTimestamp":1719984325,"startTime":"0","endTime":"0","summary":"2024年07月03日下午盘13时25分,百奥赛图-B股票出现波动,股价快速上涨5.10%。截至发稿,该股报7.600港元/股,成交量5.95万股,换手率0.05%,振幅5.26%。资金方面,该股资金流入35.814万港元,流出7.709万港元。百奥赛图-B股票所在的生物技术行业中,整体涨幅为0.61%。百奥赛图-B公司简介:北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703132525aef7b44b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703132525aef7b44b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2448044639","title":"百奥赛图-B盘中异动 快速跳水5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448044639","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448044639?lang=zh_cn&edition=full","pubTime":"2024-07-02 13:28","pubTimestamp":1719898100,"startTime":"0","endTime":"0","summary":"2024年07月02日下午盘13时28分,百奥赛图-B股票出现波动,股价快速下跌5.11%。百奥赛图-B股票所在的生物技术行业中,整体跌幅为1.00%。其相关个股中,歌礼制药-B、诺诚健华、维亚生物涨幅较大,振幅较大的相关个股有帝王国际投资、东曜药业-B、正大企业国际,振幅分别为14.06%、13.24%、11.69%。百奥赛图-B公司简介:北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702132820941f30a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702132820941f30a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2448590289","title":"百奥赛图-B(02315)股价下跌5.098%,现价港币$7.26","url":"https://stock-news.laohu8.com/highlight/detail?id=2448590289","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448590289?lang=zh_cn&edition=full","pubTime":"2024-07-02 13:28","pubTimestamp":1719898080,"startTime":"0","endTime":"0","summary":"[下跌股]百奥赛图-B(02315) 股价在下午01:28比前收市价下跌5.098%,现股价为港币$7.26。至目前为止,今日最高价为$7.76,而最低价为$7.26。总成交量为3.35万股,总成交金额为港币$25.106万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2407021466/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2446414521","title":"百奥赛图-B(02315)上涨5.68%,报7.82元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446414521","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446414521?lang=zh_cn&edition=full","pubTime":"2024-06-28 15:30","pubTimestamp":1719559844,"startTime":"0","endTime":"0","summary":"6月28日,百奥赛图-B(02315)盘中上涨5.68%,截至15:30,报7.82元/股,成交102.69万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司,拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台,已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发,已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2023年年报,百奥赛图-B营业总收入7.17亿元、净利润-3.83亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/06/28153041257643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2446221225","title":"百奥赛图-B盘中异动 下午盘快速上涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446221225","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446221225?lang=zh_cn&edition=full","pubTime":"2024-06-28 15:26","pubTimestamp":1719559618,"startTime":"0","endTime":"0","summary":"2024年06月28日下午盘15时26分,百奥赛图-B股票出现波动,股价快速上涨5.39%。百奥赛图-B股票所在的生物技术行业中,整体涨幅为0.02%。其相关个股中,盛禾生物-B、帝王国际投资、百奥赛图-B涨幅较大,振幅较大的相关个股有荃信生物-B、创胜集团-B、来凯医药-B,振幅分别为27.21%、14.00%、12.89%。百奥赛图-B公司简介:北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628152658941f234c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628152658941f234c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2446565797","title":"“中国鼠王”","url":"https://stock-news.laohu8.com/highlight/detail?id=2446565797","media":"重庆商报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446565797?lang=zh_cn&edition=full","pubTime":"2024-06-28 00:00","pubTimestamp":1719504000,"startTime":"0","endTime":"0","summary":"百奥赛图之所以能成为“中国鼠王”,跟公司创始人沈月雷的“疯狂”有着直接关联。在沈月雷的概念中,百奥赛图所做的事远不止一只“小白鼠”。2023年,百奥赛图在销售额上成为“国内模式动物三巨头”之首,前一年完成港交所挂牌上市之后,又开始筹备在科创板挂牌。但一开始,国际药企客户普遍认为中国动物房“不干净”。“千鼠万抗”应运而生2020年到2023年,公司的对外业务量受到巨大影响,沈","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062801063795df0151&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062801063795df0151&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1161","02315","BK1574"],"gpt_icon":0},{"id":"2445473302","title":"百奥赛图(02315.HK)共轻链小鼠RenLite技术平台获得美国专利授权","url":"https://stock-news.laohu8.com/highlight/detail?id=2445473302","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445473302?lang=zh_cn&edition=full","pubTime":"2024-06-21 16:44","pubTimestamp":1718959440,"startTime":"0","endTime":"0","summary":"百奥赛图-B(02315.HK) 公布,其自主研发的全人共轻链小鼠RenLite技术平台获得美国专利及商标局(United States Patent and Trademark Office)专利授权。(sl/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20221007162259565_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20221007162259565_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1358271/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2445573399","title":"百奥赛图-B(02315)全人共轻链小鼠RenLite®技术平台获美国专利及商标局专利授权","url":"https://stock-news.laohu8.com/highlight/detail?id=2445573399","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445573399?lang=zh_cn&edition=full","pubTime":"2024-06-21 16:35","pubTimestamp":1718958915,"startTime":"0","endTime":"0","summary":"百奥赛图已基于RenLite及RenLite KO小鼠生成针对200+TAA靶点的抗体库,可快速应用于双抗及双抗ADC等药物的开发。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/MWE4MzQxMzE4MTMyMDcyNjdlMDUyODUyMDM1NzM2NzM1MzQ=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MWE4MzQxMzE4MTMyMDcyNjdlMDUyODUyMDM1NzM2NzM1MzQ=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1939104","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":-0.0186},{"period":"1month","weight":-0.0147},{"period":"3month","weight":-0.0452},{"period":"6month","weight":-0.2381},{"period":"1year","weight":-0.6377},{"period":"ytd","weight":-0.3831}],"compareEarnings":[{"period":"1week","weight":-0.0146},{"period":"1month","weight":-0.031},{"period":"3month","weight":0.0156},{"period":"6month","weight":0.0776},{"period":"1year","weight":-0.0642},{"period":"ytd","weight":0.0248}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。该公司运营两个业务部门。药物开发业务部门主要从事肿瘤学和自身免疫性疾病治疗的研发,及抗体开发业务。临床前研究服务部门主要从事基因编辑、临床前药理药效评估及模式动物销售。","exchange":"SEHK","name":"百奥赛图-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥赛图-B,02315,百奥赛图-B股票,百奥赛图-B股票老虎,百奥赛图-B股票老虎国际,百奥赛图-B行情,百奥赛图-B股票行情,百奥赛图-B股价,百奥赛图-B股市,百奥赛图-B股票价格,百奥赛图-B股票交易,百奥赛图-B股票购买,百奥赛图-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}